Nang Kuang Pharmaceutical Co., Ltd.
1752
Rank in Stocks
#20074
Primarily based in Taiwan, Nang Kuang Pharmaceutical Co., Ltd. functions as a... Primarily based in Taiwan, Nang Kuang Pharmaceutical Co., Ltd. functions as a pharmaceutical enterprise. Its comprehensive product range includes various sterile injectable forms such as parenterals, aseptic parenterals, lyophilized injections, pre-filled syringes, and pre-mixed intravenous (IV) infusion bags. Additionally, it manufactures conventional dosage forms like tablets, capsules, oral suspensions, and topical applications. The company's offerings span a wide array of therapeutic categories, including treatments for cardiovascular, gastrointestinal, and nervous system disorders; alimentary and metabolic conditions; blood-related issues; antineoplastic and immunomodulatory agents; musculoskeletal and respiratory ailments; dermatological concerns; genito-urinary and sex hormone therapies; systemic hormones; and systemic antibacterials. Nang Kuang also supplies cosmetic products and comprehensive hospital solutions. Furthermore, Nang Kuang specializes in advanced pharmaceutical technologies, producing sterile and anticancer injectable products, controlled-release formulations (both injectable and oral), and oral disintegrating tablets. Founded in 1963, Nang Kuang Pharmaceutical Co., Ltd. is headquartered in Tainan City, Taiwan.
Share Price
$0.90691265
Last synced: 2026-11-10
Market Cap
$91.59M
Change (1 day)
-0.34%
Change (1 year)
-26.98%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Nang Kuang Pharmaceutical Co., Ltd. (1752)
Category
Healthcare
EPS for Nang Kuang Pharmaceutical Co., Ltd. (1752)
EPS as of June 2026 TTM: $0.06
According to Nang Kuang Pharmaceutical Co., Ltd.'s latest financial reports, its current EPS (TTM) is $0.06. At the end of 2025 the company had an EPS of $0.08, an increase over its 2024 EPS of $0.07.
EPS history for Nang Kuang Pharmaceutical Co., Ltd. from 2009 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.06 | -21.63% |
| 2025 | $0.08 | 5.04% |
| 2024 | $0.07 | 14.87% |
| 2023 | $0.06 | -43.85% |
| 2022 | $0.11 | 62.57% |
| 2021 | $0.07 | 8.02% |
| 2020 | $0.06 | -10.62% |
| 2019 | $0.07 | 121.71% |
| 2018 | $0.03 | -47.26% |
| 2017 | $0.06 | -10.66% |
| 2016 | $0.07 | 5.31% |
| 2015 | $0.07 | 174.58% |
| 2014 | $0.02 | -874.19% |
| 2013 | 0.00 | -107.38% |
| 2012 | $0.04 | 1,172.73% |
| 2011 | 0.00 | -156.90% |
| 2010 | $-0.01 | -192.06% |
| 2009 | $0.01 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $8.37 | 13,249.28% |
US
|
|
| $6.02 | 9,504.31% |
FR
|
|
| $4.15 | 6,518.82% |
US
|
|
| $5.32 | 8,385.01% |
JP
|
|
| $0.67 | 968.58% |
US
|
Questions about Nang Kuang Pharmaceutical Co., Ltd.'s earnings per share (EPS)
What is Nang Kuang Pharmaceutical Co., Ltd.'s earnings per share (EPS)?
Nang Kuang Pharmaceutical Co., Ltd.'s earnings per share (EPS) over the last twelve months is $0.06, as of Jun 2026.
What was Nang Kuang Pharmaceutical Co., Ltd.'s earnings per share (EPS) in 2025?
In 2025, Nang Kuang Pharmaceutical Co., Ltd.'s earnings per share (EPS) was $0.08, 14.29% more than in 2024 ($0.07).
How has Nang Kuang Pharmaceutical Co., Ltd.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Nang Kuang Pharmaceutical Co., Ltd.'s earnings per share (EPS) went from $0.06 to $0.08, an average growth of 5.92% a year.
How does Nang Kuang Pharmaceutical Co., Ltd.'s earnings per share (EPS) compare with similar companies?
Nang Kuang Pharmaceutical Co., Ltd.'s earnings per share (EPS) ($0.06) is lower than that of all 5 similar companies listed above. The highest among them is Intuitive Surgical, Inc., with $8.37.